Optimization of a GDNF production method based on Semliki Forest virus vector

Human glial cell line-derived neurotrophic factor (hGDNF) is the most potent dopaminergic factor described so far, and it is therefore considered a promising drug for Parkinson’s disease (PD) treatment. However, the production of therapeutic proteins with a high degree of purity and a specific glyco...

Descripción completa

Detalles Bibliográficos
Autores: Torres-Ortega, P.V. (Pablo Vicente)|||/items/773ce537-c8dd-4be3-b7e5-2f13fb5ad0de, Smerdou-Picazo, C. (Cristian)|||/items/48fd1bd4-6483-45c9-9951-8a1b04873227, Ansorena-Artieda, E. (Eduardo)|||/items/eee6c2d6-f73a-48d3-a5f8-fe090b677c82, Ballesteros-Briones, M.C. (María Cristina)|||/items/4ede3e7d-1b82-4945-a24c-a96d8e2dff71, Martisova, E. (Eva)|||/items/80cb8569-6236-4f78-b528-c3d5bfc8efde, Garbayo, E. (Elisa)|||/items/c0fa35e4-82c5-44f7-b300-740027106dba, Blanco-Prieto, M.J. (María José)|||/items/93e177db-635f-456f-b672-b79ef8befc40
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/63698
Acceso en línea:https://hdl.handle.net/10171/63698
Access Level:acceso abierto
Palabra clave:GDNF
Biphasic growth, BHK cells, Semliki Forest
Virus
Shut-off
Parkinson's disease
id ES_3df609c0fca3b51c339f275944da0a73
oai_identifier_str oai:dadun.unav.edu:10171/63698
network_acronym_str ES
network_name_str España
repository_id_str
spelling Optimization of a GDNF production method based on Semliki Forest virus vectorTorres-Ortega, P.V. (Pablo Vicente)|||/items/773ce537-c8dd-4be3-b7e5-2f13fb5ad0deSmerdou-Picazo, C. (Cristian)|||/items/48fd1bd4-6483-45c9-9951-8a1b04873227Ansorena-Artieda, E. (Eduardo)|||/items/eee6c2d6-f73a-48d3-a5f8-fe090b677c82Ballesteros-Briones, M.C. (María Cristina)|||/items/4ede3e7d-1b82-4945-a24c-a96d8e2dff71Martisova, E. (Eva)|||/items/80cb8569-6236-4f78-b528-c3d5bfc8efdeGarbayo, E. (Elisa)|||/items/c0fa35e4-82c5-44f7-b300-740027106dbaBlanco-Prieto, M.J. (María José)|||/items/93e177db-635f-456f-b672-b79ef8befc40GDNFBiphasic growth, BHK cells, Semliki ForestVirusShut-offParkinson's diseaseHuman glial cell line-derived neurotrophic factor (hGDNF) is the most potent dopaminergic factor described so far, and it is therefore considered a promising drug for Parkinson’s disease (PD) treatment. However, the production of therapeutic proteins with a high degree of purity and a specific glycosylation pattern is a major challenge that hinders its commercialization. Although a variety of systems can be used for protein production, only a small number of them are suitable to produce clinical-grade proteins. Specifically, the baby hamster kidney cell line (BHK-21) has shown to be an effective system for the expression of high levels of hGDNF, with appropriate post-translational modifications and protein folding. This system, which is based on the electroporation of BHK-21 cells using a Semliki Forest virus (SFV) as expression vector, induces a strong shut-off of host cell protein synthesis that simplify the purification process. However, SFV vector exhibits a temperature dependent cytopathic effect on host cells, which could limit hGDNF expression. The aim of this study was to improve the expression and purification of hGDNF using a biphasic temperature cultivation protocol that would decrease the cytopathic effect induced by SFV. Here we show that an increase in the temperature from 33◦C to 37◦C during the “shut-off period”, produced a significant improvement in cell survival and hGDNF expression. Inconsonance, this protocol led to the production of almost 3-fold more hGDNF when compared to the previously described methods. Therefore, a “recovery period” at 37◦C before cells are exposed at 33◦C is crucial to maintain cell viability and increase hGDNF expression. The protocol described constitutes an efficient and highly scalable method to produce highly pure hGDNF.ElsevierDadun. Depósito Académico Digital Universidad de Navarra20222022-06-2820212021-01-0120212021-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/63698reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/636982026-06-21T12:47:57Z
dc.title.none.fl_str_mv Optimization of a GDNF production method based on Semliki Forest virus vector
title Optimization of a GDNF production method based on Semliki Forest virus vector
spellingShingle Optimization of a GDNF production method based on Semliki Forest virus vector
Torres-Ortega, P.V. (Pablo Vicente)|||/items/773ce537-c8dd-4be3-b7e5-2f13fb5ad0de
GDNF
Biphasic growth, BHK cells, Semliki Forest
Virus
Shut-off
Parkinson's disease
title_short Optimization of a GDNF production method based on Semliki Forest virus vector
title_full Optimization of a GDNF production method based on Semliki Forest virus vector
title_fullStr Optimization of a GDNF production method based on Semliki Forest virus vector
title_full_unstemmed Optimization of a GDNF production method based on Semliki Forest virus vector
title_sort Optimization of a GDNF production method based on Semliki Forest virus vector
dc.creator.none.fl_str_mv Torres-Ortega, P.V. (Pablo Vicente)|||/items/773ce537-c8dd-4be3-b7e5-2f13fb5ad0de
Smerdou-Picazo, C. (Cristian)|||/items/48fd1bd4-6483-45c9-9951-8a1b04873227
Ansorena-Artieda, E. (Eduardo)|||/items/eee6c2d6-f73a-48d3-a5f8-fe090b677c82
Ballesteros-Briones, M.C. (María Cristina)|||/items/4ede3e7d-1b82-4945-a24c-a96d8e2dff71
Martisova, E. (Eva)|||/items/80cb8569-6236-4f78-b528-c3d5bfc8efde
Garbayo, E. (Elisa)|||/items/c0fa35e4-82c5-44f7-b300-740027106dba
Blanco-Prieto, M.J. (María José)|||/items/93e177db-635f-456f-b672-b79ef8befc40
author Torres-Ortega, P.V. (Pablo Vicente)|||/items/773ce537-c8dd-4be3-b7e5-2f13fb5ad0de
author_facet Torres-Ortega, P.V. (Pablo Vicente)|||/items/773ce537-c8dd-4be3-b7e5-2f13fb5ad0de
Smerdou-Picazo, C. (Cristian)|||/items/48fd1bd4-6483-45c9-9951-8a1b04873227
Ansorena-Artieda, E. (Eduardo)|||/items/eee6c2d6-f73a-48d3-a5f8-fe090b677c82
Ballesteros-Briones, M.C. (María Cristina)|||/items/4ede3e7d-1b82-4945-a24c-a96d8e2dff71
Martisova, E. (Eva)|||/items/80cb8569-6236-4f78-b528-c3d5bfc8efde
Garbayo, E. (Elisa)|||/items/c0fa35e4-82c5-44f7-b300-740027106dba
Blanco-Prieto, M.J. (María José)|||/items/93e177db-635f-456f-b672-b79ef8befc40
author_role author
author2 Smerdou-Picazo, C. (Cristian)|||/items/48fd1bd4-6483-45c9-9951-8a1b04873227
Ansorena-Artieda, E. (Eduardo)|||/items/eee6c2d6-f73a-48d3-a5f8-fe090b677c82
Ballesteros-Briones, M.C. (María Cristina)|||/items/4ede3e7d-1b82-4945-a24c-a96d8e2dff71
Martisova, E. (Eva)|||/items/80cb8569-6236-4f78-b528-c3d5bfc8efde
Garbayo, E. (Elisa)|||/items/c0fa35e4-82c5-44f7-b300-740027106dba
Blanco-Prieto, M.J. (María José)|||/items/93e177db-635f-456f-b672-b79ef8befc40
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv GDNF
Biphasic growth, BHK cells, Semliki Forest
Virus
Shut-off
Parkinson's disease
topic GDNF
Biphasic growth, BHK cells, Semliki Forest
Virus
Shut-off
Parkinson's disease
description Human glial cell line-derived neurotrophic factor (hGDNF) is the most potent dopaminergic factor described so far, and it is therefore considered a promising drug for Parkinson’s disease (PD) treatment. However, the production of therapeutic proteins with a high degree of purity and a specific glycosylation pattern is a major challenge that hinders its commercialization. Although a variety of systems can be used for protein production, only a small number of them are suitable to produce clinical-grade proteins. Specifically, the baby hamster kidney cell line (BHK-21) has shown to be an effective system for the expression of high levels of hGDNF, with appropriate post-translational modifications and protein folding. This system, which is based on the electroporation of BHK-21 cells using a Semliki Forest virus (SFV) as expression vector, induces a strong shut-off of host cell protein synthesis that simplify the purification process. However, SFV vector exhibits a temperature dependent cytopathic effect on host cells, which could limit hGDNF expression. The aim of this study was to improve the expression and purification of hGDNF using a biphasic temperature cultivation protocol that would decrease the cytopathic effect induced by SFV. Here we show that an increase in the temperature from 33◦C to 37◦C during the “shut-off period”, produced a significant improvement in cell survival and hGDNF expression. Inconsonance, this protocol led to the production of almost 3-fold more hGDNF when compared to the previously described methods. Therefore, a “recovery period” at 37◦C before cells are exposed at 33◦C is crucial to maintain cell viability and increase hGDNF expression. The protocol described constitutes an efficient and highly scalable method to produce highly pure hGDNF.
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-01-01
2021
2021-01-01
2022
2022-06-28
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/63698
url https://hdl.handle.net/10171/63698
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869406480502882304
score 15,300719